Back to search

France· FR:68220711

DARUNAVIR TEVA 800 mg, comprimé pelliculé

A darunavir product containing darunavir, registered in France by TEVA (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AE10

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDARUNAVIR TEVA 800 mg, comprimé pelli…ATCJ05AE10REGISTER NO.FR:68220711PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Darunavir is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AE10 (darunavir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Darunavir · ATC J05AE10

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of darunavir costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), the median price runs from $2.66 in United States to $16.19 in Switzerland — a ×6.1 gap.

  • France: $9.48 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Darunavir · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$16.19
  • FR France$9.48
  • US United States$2.66 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DARUNAVIR
Manufacturer
TEVA (PAYS-BAS)
Country
France (FR)
ATC code
J05AE10
ATC class
Darunavir
Defined daily dose
1.2 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930121399
    30 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 1 comprimé(s)
    EUR 156.38

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

307 interactions on record for darunavir.

Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Darunavir · interactions on record

307 records

  • 52 severe
  • 237 moderate
  • 10 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • EliglustatA16AX10severe
  • CilostazolB01AC23severe

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Darunavir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All darunavir products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Darunavir Ratiopharm
  • Cyprus · Darunavir Accord, Davarino
  • Germany · Darunasta, Darunavir Al
  • Denmark · Darunavir "sandoz", Darunavir "stada"
  • Estonia · Darunavir Auxilia, Darunavir Sandoz
  • Spain · Darunavir Aurovitas, Darunavir Kern Pharma
  • Finland · Darunavir Accord, Darunavir Medical Valley
  • United Kingdom (Northern Ireland) · Darunavir, Darunavir Accord-Uk
  • Greece · Darunavir Accord, Darunavir Vocate
  • Croatia · Darunavir Sandoz
  • Ireland · Darunavir Clonmel, Darunavir Rowex
  • Iceland · Darunavir Krka, Darunavir Medical Valley
  • Italy · Darunavir Aurobindo, Darunavir Sandoz
  • Liechtenstein · Darunavir Viatris, Prezista
  • Netherlands · Darunavir Amarox, Darunavir Glenmark
  • Norway · Darunavir Accord, Darunavir Krka
  • Poland · Darunavir Aurovitas, Darunavir Sandoz
  • Portugal · Darunavir Accord, Darunavir Farmoz
  • Romania · Darunavir Sandoz, Darunavir Teva
  • Sweden · Darunavir Accord, Darunavir Amarox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca37d75b-f94e-4d5a-b957-c93f25e80a7a
GET /v1/drugs/ca37d75b-f94e-4d5a-b957-c93f25e80a7a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68220711",
  "date_amm": "2018-02-08",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "DARUNAVIR",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about darunavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.